Abstract
Akt2, a homolog of Akt1, encodes a serine/threonine protein kinase that is amplified in ovarian and pancreatic cancers. The antiapoptotic activities of the Akt1 proto-oncogene product have been well documented, but the role of Akt2 in cellular survival is poorly understood. Here, we demonstrate that Akt2 mRNA, protein and kinase activity are upregulated during serum deprivation-induced C2C12 cell myogenic differentiation, a process that is associated with the acquisition of an apoptosis-resistant phenotype. Transient transfection of plasmids encoding wild-type and constitutively-active Akt2 conferred resistance against apoptosis in differentiating C2C12 cells, while a kinase-negative Akt2 construct did not. Adenovirus-mediated transfer of the constitutively-active Akt2 cDNA also suppressed apoptosis during serum deprivation-induced myogenic differentiation and it protected cells from apoptosis induced by cell detachment. These data indicate that Akt2 functions as an anti-apoptotic gene during cellular differentiation, a property that may contribute to its oncogenicity. Cell Death and Differentiation (2001) 8, 1207–1212
Similar content being viewed by others
Introduction
Akt2, a serine-threonine protein kinase, is a member of Akt/protein kinase B (PKB) proto-oncogene family.1 Both Akt1 and Akt2 function as signal transducers downstream of phosphatidylinositol 3-kinase (PI 3-kinase).2,3 Akt1 and Akt2 are encoded by separate genes and are most divergent at their carboxy-terminal regions.3 Although it is well established that Akt1 functions as a regulator of glycogen metabolism, growth and survival,4 much less is known about the cellular functions of Akt2. Previously, we demonstrated that Akt1 mRNA is expressed ubiquitously, while Akt2 is expressed in a tissue specific manner and is abundant in striated muscles and brown fat.5,6,7 Of particular note, the Akt2 gene is amplified in 10–20% of ovarian and pancreatic cancers,8,9 while recurrent amplification of Akt1 has not been observed, suggesting that overexpression of Akt2 contributes to development of some human malignancies. In transformed cells, Akt2 is activated by growth factors, v-ras, and v-src through a PI 3-kinase-mediated mechanism, promoting cell cycle activity and oncogenicity in this context.10,11 Deletion of the carboxy-terminal tail in Akt2 abolishes its oncogenic activity.11
In contrast to Akt2, it is well recognized that Akt1 inhibits apoptotic cell death in diverse cell types through its ability to phosphorylate and modulate the activities of apoptosis-regulatory molecules including Bad, caspase 9, a forkhead transcription factor and IkB.1 Previously, we reported that differentiating myocytes which fail to exit the cell cycle under serum-deprivation conditions will initiate programmed cell death, whereas myocytes that successfully exit the cell cycle will acquire an apoptosis-resistant phenotype and go on to form mature myotubes.12 Related studies showed that the myogenic induction of the cell cycle inhibitor p21 and the retinoblastoma protein are essential for successful cell cycle exit, and hence, cellular survival.13,14,15,16 More recently, we demonstrated that cell cycle exit is essential for efficient Akt1 induction during myogenesis and that the induction of Akt1 is important for myocyte survival.17
Antisense RNA to Akt29 and drugs that interfere with Akt2 signaling18 inhibit the tumorigenic phenotype and induce apoptosis in cancer cells that exhibit Akt2 overexpression, consistent with the hypothesis that Akt2 gene amplification promotes cellular survival in tumors. However, nothing is known about the functions of Akt2 in non-tumorigenic cells. Here, we report that Akt2 protein and kinase activity are markedly upregulated during serum deprivation-induced myogenic differentiation in C2C12 cells. Under these conditions, transient transfection of plasmids expressing wild-type or constitutively-active Akt2 promoted myocyte survival. Furthermore, overexpression of Akt2 by adenovirus-mediated gene transfer protected against both differentiation-associated apoptosis and anoikis, cell death that results from the disruption of cell-matrix contacts.19 These data provide evidence to suggest that Akt2 induction can promote survival in nontransformed cells in response to diverse cellular stresses.
Results
Akt2 protein and kinase activity are upregulated during myogenic differentiation
Initial experiments examined Akt2 regulation during myogenic differentiation in C2C12 cells. Like Akt1,17 Akt2 protein and histone-kinase activity was expressed at low levels in cycling myoblast cultures in growth medium (GM) (Figure 1A). Two days after cultures were shifted to differentiation media (DM), there was a marked induction of Akt2 protein relative to cdk4, which does not change upon differentiation.20,21 Akt1 and Akt2 activity was assessed by determining the histone H2B kinase activity in anti-Akt1 and anti-Akt2 immunoprecipitates from extracts prepared from C2C12 cultures in GM or DM for 2 days (Figure 1B). Corresponding to the induction of protein, kinase activities for both Akt1 and Akt2 were induced to similar levels upon myogenic differentiation. Upregulation of Akt2 transcript was also observed at both day 1 and 2 after C2C12 cells were switched to differentiation media (Figure 1C). Densiometric scanning indicated a fourfold upregulation by 1 day.
To examine myogenic Akt2 protein induction in greater detail, we analyzed its expression in a 10T1/2 cell line that is stably transformed with MyoD15. These MyoD-transformed cells differ from the parental 10T1/2 line in that they form multinucleated myotubes when exposed to differentiation medium. Differentiating 10T1/2-MyoD cells upregulated Akt2 protein, whereas Akt2 was induced when parental 10T1/2 cells were exposed to differentiation media (Figure 1D). Thus, Akt2 induction requires myogenic bHLH factor-induced commitment to differentiation.
Finally, Akt2 protein half-life was examined in C2C12 cells cultured in the presence of cyclohexamide in growth medium or differentiation medium (Figure 1E). In contrast to Akt1,17 no changes in Akt2 protein stability were detected. Collectively, these data show that the induction of Akt2 protein during myogenesis is due to changes in the level of its transcript.
Transient transfection of Akt2 promotes cell survival in C2C12 cell:
As reported previously,12,14,17 a portion of C2C12 cells will undergo apoptotic cell death prior to cell cycle withdrawal when exposed to DM. To analyze the effects of Akt2 on cell survival, plasmid vector alone (pcDNA3) or vector expressing wild-type and mutated forms of Akt2 were co-transfected with a GFP expression vector to mark transfected cells. After cells were cultured in GM overnight, the medium was changed to serum-free DMEM. The fraction of GFP-positive cells with pyknotic nuclei, a feature of apoptosis, was determined at 24 h (Figure 2A). As shown in Figure 2B, transfection with wild-type Akt2 or myrAkt2 resulted in a significantly lower frequency of GFP-positive cells with pyknotic nuclei compared with vector alone. Furthermore, a vector expressing a kinase-negative form of Akt2 (knAkt2), with a mutation in the active site at amino acid 299 which converts a glutamate residue to lysine, displayed no protective effect during serum deprivation-induced myogenic differentiation.
Adenoviral transfer of constitutively-active Akt2 confers resistance to anoikis and apoptosis induced by myogenic differentiation:
To further analyze the anti-apoptotic properties of Akt2, replication-defective adenoviral vectors expressing HA-tagged kinase-negative (Adeno-knAkt2) and constitutively-active Akt2 (Adeno-myrAkt2) were constructed (Figure 3A). C2C12 cells infected with Adeno-knAkt2 or Adeno-myrAkt2 expressed comparable levels of transgene as determined by immunoblot analysis with anti-HA antibody (Figure 3B). No immunoblot signal was detected in C2C12 cells infected with a control adenovirus vector that expresses β-galactosidase (Adeno-βgal) from the CMV promoter. The expression levels of knAkt2 and myrAkt2 adenovirus transgenes relative to endogenous Akt2 protein is shown in Figure 3C.
To analyze the anti-apoptotic effects of Akt2 during mitogen deprivation-induced myogenesis, myoblast cultures were mock-infected or infected with Adeno-βgal, Adeno-knAkt2, or Adeno-myrAkt2 and then induced to differentiate in serum-free DMEM. Flow cytometric analysis revealed a large fraction of cells containing hypodiploid DNA, an indicator of apoptotic cell death, in the mock, Adeno-βgal and Adeno-knAkt2 experimental conditions (Figure 4). In contrast cells infected with Adeno-myrAkt2 displayed a reduced fraction of hypodiploid DNA indicating a reduction in apoptosis.
Previously, it has been reported that Akt1 protects against anoikis in endothelial and epithelial cells.20,22 To test whether Akt2 has a similar function in muscle cells, that also undergo anoikis,23 myoblast cultures were transfected with Adeno-βgal or Adeno-myrAkt2 and cultured in BSA-coated bacterial plates to prevent adhesion. After 24 h in suspension culture, DNA content was analyzed to assess apoptosis. As shown in Figure 5, a large fraction of the total DNA was hypodiploid in the mock- and Adeno-βgal-transduced cultures. In contrast, infection with Adeno-myrAkt markedly reduced the fraction of the DNA in the sub-G1 population, indicating that constitutive activation of Akt2 is sufficient to promote survival in the absence of cellular adhesion. Infection with Adeno-knAkt2 had no detectable effect on the fraction of cells undergoing anoikis relative to mock- and Adeno-βgal-transduced cultures (data not shown).
Discussion
In this study we demonstrate that Akt2 can promote survival under conditions where non-tumorigenic cells are deprived of mitogens or proper matrix associations. Transient transfection of plasmids encoding either wild-type or constitutively-active Akt2 was found to inhibit apoptosis in C2C12 myocytes that are induced to differentiate under low serum culture conditions. These data were corroborated by the observation that adenovirus-mediated expression of constitutively-active Akt2 also promotes survival in differentiating myocyte cultures. Constitutively-active Akt2 also inhibits anoikis, apoptotic cell death that occurs in non-transformed cells when their substratum-cell adhesions are disrupted.19,23 Collectively, these data suggest that Akt2 can modulate both growth factor- and matrix attachment-mediated survival signals.
This study also demonstrates that both Akt2 protein and protein kinase activity are upregulated during myogenic differentiation in C2C12 cells and in 10T1/2 cells that are transformed with MyoD. These data are consistent with the observation that Akt2 mRNA is induced in myogenic cell lines upon differentiation.5,6 At the levels of activity and protein, the upregulation of Akt2 is similar to that of Akt1 (see Figure 1). However, the mechanism of the upregulation is different for Akt1 and Akt2. Myogenic induction of Akt2 is mediated by an increase in transcript,5,6 while induction of Akt1 occurs through stabilization of the protein with no accompanying change in mRNA levels.17 Data from the current study also suggest that Akt2 induction may function to protect differentiating myocytes from apoptosis. Overexpression of wild-type Akt2 suppressed apoptosis to a similar degree as constitutively-active Akt2. Presumably, the wild-type transgene is activated by insulin-like growth factor-II (IGF-II) which is produced by differentiating myocytes.24,25,26 In this regard, it has been shown that IGF-II functions as an autocrine survival factor during myoblast differentiation.27,28
Finally, the anti-apoptotic activities of Akt2 described here may contribute to its role in malignancy and explain why Akt2 gene amplification is observed in pancreatic and ovarian cancers.8,9 It is well recognized that anti-apoptotic genes contribute to malignancy. In particular, anoikis prevents detached cells from colonizing in inappropriate locations, thereby protecting against metastasis.29 Thus, our observation that enhanced Akt2 signaling can confer resistance to anoikis suggests that the amplification and/or overexpression of this factor may contribute to tumor formation and invasiveness. Therefore, as an anti-apoptotic signal transducer, Akt2 could have a role in controlling cell survival during normal differentiation as well as contribute to the development of human malignancies.
Materials and Methods
Cell Culture
C2C12 cells were cultured as described previously.13 Cells were maintained in growth medium (GM) which consists of Dulbecco's modified Eagle medium (DMEM) containing 20% fetal calf serum. Differentiation was induced by switching GM to differentiation medium (DM) which consists of serum-free DMEM or DMEM plus 2% heat-inactivated horse serum. Suspension cultures were obtained as described in.20 Briefly, cells were washed with phosphate-buffered saline (PBS) twice and harvested with PBS containing 0.5% EDTA. Cells were collected by centrifugation, resuspended in DMEM, and cultured on bacterial culture dishes precoated with 20 mg/ml bovine serum albumin (BSA). 10T1/2 cells and MyoD-transformed 10T1/2 cells were cultured as described previously.15 Cells were maintained in GM, and switched to DM for 2 days.
Northern blot analyses
Northern blotting was performed as described previously.17 Briefly, total RNA was prepared with the acid guanidium thiocyanate-phenol-chloroform method.29 Total RNA (25 μg) was separated in formaldehyde gel and transferred to a Hybond N membrane. The cDNA fragment corresponding to the pleckstrin homology domain of mouse Akt was used as a probe. After hybridization and washing, membranes were exposed to X-ray film overnight.
Immunoblot analyses
Immunoblot analyses were performed as described in.17 In brief, cells were washed twice in PBS on ice and extracted with cell lysis buffer (1% Nonidet P-40, 10% glycerol, 137 mM NaCl, 20 mM Tris-HCl [pH 7.4], 20 mM NaF, 1 mM phenylmethyl-sulfonyl fluoride) for 15 min. at 4°C, followed by centrifugation at 15 000 r.p.m. for 15 min. Twenty micrograms of protein were separated on SDS polyacrylamide gel. Proteins were transferred onto a polyvinylidine difluoride membrane (Millipore). After blocking with 5% nonfat milk protein, the membranes were incubated with anti-Akt1 (Santa Cruz), anti-Akt2 (Upstate), anti-cdc2 (Santa Cruz), anti-hemagglutinin (HA) (Boehringer), or anti-Cdk4 antibody (Santa Cruz). Blots were incubated with the secondary antibody conjugated with horse-radish peroxidase (donkey anti-goat (Santa Cruz), donkey anti-rabbit (Amersham), or rabbit anti-sheep (Pierce). An enhanced chemiluminescence protocol was used for detection according to the directions of the manufacturer (Amersham Life Science).
Akt2 half-life determinations
Cultures of C2C12 cells were incubated in growth medium or differentiation media for two days. Parallel cultures were then exposed to 35 μM cyclohexamide and lysates were prepared after 2, 4 and 6 h. Western immunoblots were performed to determine Akt2 levels relative to the level of cdc2, which remains constant under these conditions.30
Akt protein kinase assays
Cell lysates were prepared as described above. Cell lysates (200 μg per assay) were immunoprecipitated with anti-Akt1 or Akt2 antibody using protein G agarose (Boehringer). After two washes with lysis buffer, one wash with H2O, and two washes with kinase buffer (20 mM HEPES [pH 7.2], 10 mM MgCl2, 10 mM MnCl2), kinase assays were performed as described previously17 using histone H2B as a substrate.
Transient transfection and cell viability analysis
Plasmids included vector (pcDNA3) with no insert or encoding wild-type Akt2, kinase-negative Akt2 (knAkt2), or constitutively-active Akt2 (myrAkt2) expressed from the cytomegalovirus (CMV) promoter/enhancer.31 Plasmids were cotransfected with an expression vector encoding enhanced green fluorescent protein (GFP) (Clontech) with LipofectAmine as described in.17 After 18 h incubation in GM, apoptosis was induced by changing GM to serum-free medium. After incubated for 24 h, cells were fixed with 3.7% formaldehyde in PBS and stained with Hoechst 33342. GFP-positive cells with pyknotic nuclei were determined by visual examination.
Adenovirus construction and transfection
Replication-defective adenovirus vectors were constructed according to.32 Briefly, knAkt2 or myrAkt2 cDNAs, fused at their N-terminus to the hemagglutinin epitope (HA), were inserted into the multicloning site of pACCMVpLpA. The resulting plasmids were cotransfected with pJM17 into 293 cells to allow for homologous recombination. An adenovirus construct expressing β-galactosidase from the CMV promoter/enhancer was used as a control.33 All constructs were amplified in 293 cells and purified by ultracentrifugation in the presence of CsCl. For transfection, C2C12 cells were incubated with adenovirus vectors in GM for 15 h. C2C12 cells were infected at a multiplicity of infection (MOI) of 250, which leads to >95% efficiency of transgene transduction.17
Flow cytometry
DNA content of adenovirus construct-infected or mock-infected cells was measured with a FACScan flow cytometer (Becton Dickson) as described in.14
Abbreviations
- PKB:
-
protein kinase B
- GM:
-
growth medium
- DM:
-
differentiation medium
- GFP:
-
green fluorescence protein
- DMEM:
-
Dulbecco's modified Eagle medium
- IGF:
-
insulin-like growth factor
- HA:
-
hemagglutinin
- PBS:
-
phosphate-buffered saline
- CMV:
-
cytomegalovirus
- MOI:
-
multiplicity of infection
References
Datta SR, Brunet A, Greenberg ME . 1999 Cellular survival: a play in three Akts Genes Dev. 13: 2905–2927
Franke TF, Yang S-I, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN . 1995 The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phophatidylinositol 3-kinase Cell. 81: 727–736
Testa JR, Bellacosa A . 1997 Membrane translocation and activation of the Akt kinase in growth factor-stimulated hematopoietic cells Leukemia Res. 21: 1027–1031
Coffer PJ, Jin J, Woodgett JR . 1998 Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation Biochem. J. 335: 1–13
Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, Testa JR . 1995 Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene Oncogene. 11: 1055–1060
Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR . 1998 Akt2 mRNA is highly expressed in embryonic brown fat and AKT2 kinase is activated by insulin Oncogene. 16: 2407–2411
Calera MR, Pilch PF . 1998 Induction of Akt-2 correlates with differentiation in Sol8 muscle cells Biochem. Biophys. Res. Commun. 251: 835–841
Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR . 1992 AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc. Natl. Acad. Sci. USA. 89: 9267–9271
Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR . 1996 Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc. Natl. Acad. Sci. USA. 93: 3636–3641
Liu A, Testa JR, Hamilton TC, Jove R, Nicosia SV, Cheng JQ . 1998 AKT2, a member of protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells Cancer Res. 58: 2973–2977
Cheng JQ, Altomare DA, Klein MA, Lee WC, Kruh GD, Lissy NA, Testa JR . 1997 Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis Oncogene. 14: 2793–2801
Wang J, Walsh K . 1996 Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation Science. 273: 359–361
Andrés V, Walsh K . 1996 Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis J. Cell Biol. 132: 657–666
Wang J, Guo K, Wills KN, Walsh K . 1997 Rb functions to inhibit apoptosis during myocyte differentiation Cancer Res. 57: 351–354
Guo K, Wang J, Andrés V, Smith RC, Walsh K . 1995 MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation Mol. Cell Biol. 15: 3823–3829
Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL . 1996 pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis Genes Dev. 10: 3051–3064
Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa JR, Walsh K . 1999 Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival Mol. Cell Biol. 19: 5073–5082
Jiang K, Coppola D, Crespo NC, Nicosia SV, Hamilton AD, Sebti SM, Cheng JQ . 2000 The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis Mol. Cell Biol. 20: 139–148
Frisch SM, Francis H . 1994 Disruption of epithelial cell-matrix interactions induces apoptosis J. Cell Biol. 124: 619–626
Fujio Y, Walsh K . 1999 Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner J. Biol. Chem. 274: 16349–16354
Wang J, Walsh K . 1996 Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex Cell Growth Diff. 7: 1471–1478
Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J . 1997 Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway EMBO J. 16: 2783–2793
Vachon PH, Loechel F, Xu H, Wewer UM, Engvall E . 1996 Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival J. Cell Biol. 134: 1483–1497
Rosen KM, Wentworth BM, Rosenthal N, Villa-Komaroff L . 1993 Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation Endocrinology. 133: 474–481
Florini JR, Ewton EZ, Magri KA . 1991 Hormones, growth factors and myogenic differentiation Annu. Rev. Physiol. 53: 201–216
Tollefsen SE, Sadow JL, Rotwein P . 1989 Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation Proc. Natl. Acad. Sci. USA. 86: 1543–1547
Steele PM, Chesebro JH, Stanton AW, Holmes DR, Dewanjee MK, Badimon L, Fuster V . 1985 Balloon Angioplasty; natural history of the pathophysiological response to injury in a pig model Circ. Res. 57: 105–112
Stewart CEH, Rotwein P . 1996 Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts J. Biol. Chem. 271: 11330–11338
Chomczynski P, Sacchi N . 1987 Single-step method of RNA isolation by acid guanidinium Thiocyanate-Phenol-Chloroform Extraction Anal. Biochem. 162: 156–159
Song A, Wang Q, Goeble MG, Harrington MA . 1998 Phosphorylation of nuclear MyoD is required for its rapid degradation Mol. Cell Biol. 18: 4994–4999
Mitsuuchi Y, Johnson SW, Moonblatt S, Testa JR . 1998 Translocation and activation of AKT2 in response to stimulation by insulin J. Cell Biochem. 70: 433–441
Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB . 1994 Use of recombinant adenovirus for metabolic engineering of mammalian cells. In Methods in Cell Biology New York, NY: Academic Press pp. 161–189
Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu J-F, Pastore C, Mahfoudi A, Denèfle P, Isner JM, Walsh K . 1997 p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene Genes Dev. 11: 1674–1689
Acknowledgements
This work was supported by NIH grants HD-23681, AR-40197 and AG-15052 to K Walsh and NCI grants CA-77429 and CA-06927 to JR Testa.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by DR Green
Rights and permissions
About this article
Cite this article
Fujio, Y., Mitsuuchi, Y., Testa, J. et al. Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiation. Cell Death Differ 8, 1207–1212 (2001). https://doi.org/10.1038/sj.cdd.4400919
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400919
Keywords
This article is cited by
-
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer
Cancer Cell International (2024)
-
PKN2 and Cdo interact to activate AKT and promote myoblast differentiation
Cell Death & Disease (2016)
-
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
Molecular Cancer (2010)